A study recently asked users of psychedelic substances to share their experiences with the drugs and, in particular, their bad trips. The study, which was reported in the “International Journal of Drug Policy,” found that many users of psychedelic substances used storytelling to redefine bad trips and make them positive experiences.
Hallucinogens, or psychedelics, are psychoactive substances that activate altered states of consciousness, influencing an individual’s cognition, perception and mood. Hallucinogens are considered to be low in toxicity and aren’t addictive, but they can sometimes cause challenging trips, which are basically negative reactions that can include frightening hallucinations, panic attacks, paranoia and anxiety.
Despite having these unpleasant experiences, psychedelic users embraced the positives in bad trips, observed the researchers. Researchers included Liridona Gashi, Willy Pedersen and Sveinung Sandberg, who suggest that storytelling may be useful in helping users of psychedelics find meaning in challenging trips.
For their study, the researchers recruited 50 psychedelic users who were in their early 20s and late 30s; the teams then conducted interviews with those users. The team found that psilocybin and LSD were the most commonly used drugs, noting that most of the participants had used psychedelics less than 50 times.
During the interviews, each participant was asked questions about their experiences with bad trips, including how they felt a day after the trip, if the experience had changed them and how scared they were. In their study, the researchers noted that apart from two participants, the remaining number had experienced bad trips.
Similar to prior findings, most stories included troubling visions, panic attacks, confusion and paranoia. The researchers added that the majority of the participants also described intense feelings of losing their sense of self or going insane.
Despite these negative experiences, most participants recalled their trips with gratitude, which proposes that the experiences had unearthed feelings that had been repressed and provided them with deep insights into various matters. In addition, some participants suggested that bad trips mainly arise due to the lack of competence of the drug user.
The researchers also stated that the stories on bad trips were extremely detailed and rich, noting that the psychedelic users were adept at storytelling and had extensive vocabularies. The researchers suggest that these narratives may help explain why bad trips can be interpreted as both positive and negative experiences at the same time, adding that storytelling may play the role of a coping mechanism, assisting the individuals to draw meaning from the negative experiences and process their emotions.
The possibility of a bad trip may be the reason why a variety of companies, including Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), see psychedelics as medicinal formulations that should only be used under the watchful eye of trained medical personnel.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
